A synthetic peptide for use as a blocking control in assays to test for specificity of FCER1 A antibody, Alternative Names: FCER1A control peptide, FCER1A antibody Blocking Peptide, Anti-FCER1A Blocking Peptide, Fc Fragment Of Ige High Affinity I Receptor For, Alpha Polypeptide Blocking Peptide, FCE1A Blocking Peptide, FcERI Blocking Peptide, FCER1A, FCERA-1, FCERA 1, FCERA-1 Blocking Peptide, FCERA 1 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
Fc epsilon RI/FCER1A (FCER1A)
(Fc Fragment of IgE Receptor Ia (FCER1A))
Synonyme
FCER1A Peptide, FCE1A Peptide, FcERI Peptide, Iger01 Peptide, RATIGER01 Peptide, Fce1a Peptide, Fcr-5 Peptide, fcepsilonri Peptide, Fc fragment of IgE receptor Ia Peptide, Fc receptor, IgE, high affinity I, alpha polypeptide Peptide, FCER1A Peptide, Fcer1a Peptide
Hintergrund
The IgE receptor plays a central role in allergic disease, coupling allergen and mast cell to initiate the inflammatory and immediate hypersensitivity responses that are characteristic of disorders such as hay fever and asthma. The allergic response occurs when 2 or more high-affinity IgE receptors are crosslinked via IgE molecules that in turn are bound to an allergen (antigen) molecule. A perturbation occurs that brings about the release of histamine and proteases from the granules in the cytoplasm of the mast cell and leads to the synthesis of prostaglandins and leukotrienes--potent effectors of the hypersensitivity response.